Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
Article in Human Vaccines & Immunotherapeutics (August 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Human Vaccines & Immunotherapeutics (August 2024)
Article in Human Vaccines & Immunotherapeutics (May 2024)
Article in Antiviral Research (March 2024)